글로벌 텔로겐 탈모증 치료 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 휴지기 탈모증 치료 시장

텔로겐 탈모 치료 시장은 2021-2028년 예측 기간에 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에서 언급한 예측 기간에 시장이 6.80%의 CAGR로 성장할 것으로 분석합니다.

텔로겐 탈모는 스트레스, 충격 또는 외상으로 인해 발생하는 일종의 일시적인 탈모입니다. 일반적으로 정수리에서 시작됩니다. 텔로겐 탈모는 탈모 상태인 원형 탈모증과 다릅니다. 사람의 머리카락이 대량으로 빠질 수 있지만 이는 일반적으로 일시적이며 머리카락은 다시 자랍니다. 이 장애는 일반적으로 여성에게 나타나며 자연스러운 모발 주기의 혼란으로 인해 발생합니다. 텔로겐 탈모는 모발 주기의 텔로겐 또는 휴지기 동안 발생하는 상태로, 성장기 또는 성장 단계와 퇴행기 또는 과도기 이후에 발생합니다. 텔로겐 탈모가 있는 환자의 경우 성장기 단계가 느려지고 다음 두 단계로 들어가는 머리카락이 매우 적어 결과적으로 탈모가 발생합니다.

텔로겐 탈모증의 유병률 증가와 의료비 지출 증가는 시장 성장률에 영향을 미치는 주요 요인입니다. 나아가 수면 부족, 열악한 식단, 공공 및 민간 기관에서 질병과 이용 가능한 치료법에 대한 인식을 확산하기 위한 이니셔티브가 증가하면서 텔로겐 탈모증 치료 시장이 확대될 것입니다. 스트레스와 불안의 증가, 가처분 소득 수준의 증가, 알코올 소비 와 흡연 증가를 포함한 다른 요인은 시장 성장률에 긍정적인 영향을 미칠 것입니다.

2021~2028년 예측 기간 동안 연구 개발 활동의 증가와 지속적인 임상 시험은 휴지기 탈모 치료 시장에 유익한 기회를 제공할 것입니다.

However, high cost of the treatment and complications associated with the disease are the factors that will hinder the market growth. Lack of awareness will further challenge the telogen effluvium treatment market in the forecast period mentioned above.

This telogen effluvium treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the telogen effluvium treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Telogen Effluvium Treatment Market Scope and Market Size

The telogen effluvium treatment market is segmented on the basis of treatment, diagnosis, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of treatment, the telogen effluvium treatment market is segmented into medication, hormone replacement therapy, nutritional supplements, non-surgical hair replacement, shampoos and conditioners, and others.
• On the basis of diagnosis, the telogen effluvium treatment market is segmented into physical examination, blood tests, hair pull test, and others.
• On the basis of dosage, the telogen effluvium treatment market is segmented into tablet, injection, ointment, and others.
• On the basis of route of administration, the telogen effluvium treatment market is segmented into oral, injectable, topical, and others.
• On the basis of end-users, the telogen effluvium treatment market is segmented into clinic, hospital and others.
• The telogen effluvium treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Telogen Effluvium Treatment Market Country Level Analysis

Telogen effluvium treatment market is analyzed and market size information is provided by the country, treatment, diagnosis, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the telogen effluvium treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the telogen effluvium treatment market due to presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Telogen effluvium treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Telogen Effluvium Treatment Market Share Analysis

Telogen effluvium treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to telogen effluvium treatment market research.

Telogen Efluvium 치료 시장 보고서에 포함된 주요 기업으로는 Sun Pharmaceutical Industries Ltd., Merck Sharp & Dohme Corp., Dr. Reddy's Laboratories Ltd., Cipla Inc., AstraZeneca, Johnson & Johnson Private Limited, HIMS, Inc., Ultrax Labs, Nutraceutical Wellness Inc., Nanogen, Dr. Kurt Wolff GmbH & Co. KG 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-67185